How to use the speech recognition tool?
Argus II retinal prosthesis system post-market surveillance study protocol (Argus II PM-01-01)
Argus II retinal prosthesis system post-market surveillance study protocol (Argus II PM-01-01).
Status of the trial: Completed
Orphan Drug Recognition: No
- Opening Date: 2011-11-01
- Closing Date: 2021-05-01
Inclusion: Adults, age 25 or older, with severe to profound outer retinal degeneration (not including Age-related Macular Degeneration)
Funder Type: governmental organisation
Principal location of the trial
HCP: Principal investigators
Within ERN-EYE members
- Retinal Rare Eye Diseases (WG1)
This ERN is supported by: